Jung SY - Search Results

1

Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss.

Jung SY, Kim S, Kang Z, Kwon S, Lee J, Park JW, Kim KS, Kim DK. Jung SY, et al. Drug Deliv. 2022 Dec;29(1):149-160. doi: 10.1080/10717544.2021.2021320. Drug Deliv. 2022. PMID: 34967280 Free PMC article.

2

Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy.

Yang KJ, Son J, Jung SY, Yi G, Yoo J, Kim DK, Koo H. Yang KJ, et al. Among authors: jung sy. Biomaterials. 2018 Jul;171:133-143. doi: 10.1016/j.biomaterials.2018.04.038. Epub 2018 Apr 16. Biomaterials. 2018. PMID: 29689410

3

α-Lipoic acid prevents against cisplatin cytotoxicity via activation of the NRF2/HO-1 antioxidant pathway.

Lee J, Jung SY, Yang KJ, Kim Y, Lee D, Lee MH, Kim DK. Lee J, et al. Among authors: jung sy. PLoS One. 2019 Dec 26;14(12):e0226769. doi: 10.1371/journal.pone.0226769. eCollection 2019. PLoS One. 2019. PMID: 31877176 Free PMC article.

4

Intratympanic administration of alpha-lipoic acid-loaded pluronic F-127 nanoparticles ameliorates acute hearing loss.

Jung SY, Yoo J, Yang KJ, Jang SY, Yi G, Kim DK, Koo H. Jung SY, et al. Nanomedicine. 2021 Feb;32:102329. doi: 10.1016/j.nano.2020.102329. Epub 2020 Nov 10. Nanomedicine. 2021. PMID: 33181275

5

Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.

Im DS, Shin HJ, Yang KJ, Jung SY, Song HY, Hwang HS, Gil HW. Im DS, et al. Among authors: jung sy. Toxicol Lett. 2017 Aug 5;277:9-17. doi: 10.1016/j.toxlet.2017.05.023. Epub 2017 May 23. Toxicol Lett. 2017. PMID: 28549670

6

Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells.

Lee KW, Jung SY, Choi SM, Yang EJ. Lee KW, et al. Among authors: jung sy. BMC Complement Altern Med. 2012 Oct 26;12:196. doi: 10.1186/1472-6882-12-196. BMC Complement Altern Med. 2012. PMID: 23102375 Free PMC article.

7

Exploring the effects of expert-led qigong and self-practice qigong on blood pressure.

Park JE, Yang CS, Jung SY, Kim AR, Lee M, Choi SM. Park JE, et al. Among authors: jung sy. Integr Med Res. 2019 Dec;8(4):271-272. doi: 10.1016/j.imr.2019.11.004. Epub 2019 Nov 12. Integr Med Res. 2019. PMID: 31788421 Free PMC article. No abstract available.

8

Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E₂ Receptor EP4 Pathway.

Hong YA, Yang KJ, Jung SY, Park KC, Choi H, Oh JM, Lee SJ, Chang YK, Park CW, Yang CW, Kim SY, Hwang HS. Hong YA, et al. Among authors: jung sy. Oxid Med Cell Longev. 2017;2017:5031926. doi: 10.1155/2017/5031926. Epub 2017 Mar 29. Oxid Med Cell Longev. 2017. PMID: 28465762 Free PMC article.

9

Corrigendum to "Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E₂ Receptor EP4 Pathway".

Hong YA, Yang KJ, Jung SY, Park KC, Choi H, Oh JM, Lee SJ, Chang YK, WheePark C, Yang CW, Kim SY, Hwang HS. Hong YA, et al. Among authors: jung sy. Oxid Med Cell Longev. 2017;2017:1913954. doi: 10.1155/2017/1913954. Epub 2017 Aug 13. Oxid Med Cell Longev. 2017. PMID: 28883900 Free PMC article.

10

Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.

Hong YA, Jung SY, Yang KJ, Im DS, Jeong KH, Park CW, Hwang HS. Hong YA, et al. Among authors: jung sy. Int J Mol Sci. 2020 May 19;21(10):3583. doi: 10.3390/ijms21103583. Int J Mol Sci. 2020. PMID: 32438631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,396 results

Search Page

Filters